⌘K

Login Start Free

Home/Filings/4/0001144204-13-010559

4//SEC Filing

Nguyen Binh 4

Accession 0001144204-13-010559

CIK 0001235007other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:30 PM ET

Size

5.3 KB

Accession

0001144204-13-010559

Insider Transaction Report

Form 4

Period: 2013-02-19

ENDOCYTE INCECYT

VP of Clinical Affairs

Transactions

Award
Stock Option (right to buy)
2013-02-19+70,000→ 70,000 total
Exercise: $9.86Exp: 2023-02-19→ Common Stock (70,000 underlying)

Footnotes (1)

[F1]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 19, 2014.

Documents

1 file

4
v335834_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeother

Related Parties

1

filerCIK 0001523662

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 5:30 PM ET
Size: 5.3 KB

View on SEC.gov